Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82


Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.

Powell JT, Sweeting MJ, Ulug P, Blankensteijn JD, Lederle FA, Becquemin JP, Greenhalgh RM; EVAR-1, DREAM, OVER and ACE Trialists..

Br J Surg. 2017 Feb;104(3):166-178. doi: 10.1002/bjs.10430. Review.


The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

Wilkinson T, Sculpher MJ, Claxton K, Revill P, Briggs A, Cairns JA, Teerawattananon Y, Asfaw E, Lopert R, Culyer AJ, Walker DG.

Value Health. 2016 Dec;19(8):921-928. doi: 10.1016/j.jval.2016.04.015.


Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG.

JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195. Erratum in: JAMA. 2016 Nov 8;316(18):1924.


Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.

Prendergast AJ, Szubert AJ, Berejena C, Pimundu G, Pala P, Shonhai A, Musiime V, Bwakura-Dangarembizi M, Poulsom H, Hunter P, Musoke P, Kihembo M, Munderi P, Gibb DM, Spyer M, Walker AS, Klein N; ARROW Trial Team..

J Infect Dis. 2016 Jul 15;214(2):226-36. doi: 10.1093/infdis/jiw148.


Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team..

BMC Med. 2016 Mar 23;14:50. doi: 10.1186/s12916-016-0593-7.


Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5).

Ross Terres JA, Lozano-Ortega G, Kendall R, Sculpher MJ.

BMC Cardiovasc Disord. 2015 Dec 29;15:180. doi: 10.1186/s12872-015-0175-1.


Establshing The Cost-Effectiveness of Genomic-Based Diagnostic Tests: Are Current Methods Sufficient and Appropriate?

Spackman E, Hinde S, Bojke L, Payne K, Sculpher MJ.

Value Health. 2015 Nov;18(7):A727. doi: 10.1016/j.jval.2015.09.2769. No abstract available.


Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.

Musoke P, Szubert AJ, Musiime V, Nathoo K, Nahirya-Ntege P, Mutasa K, Williams DE, Prendergast AJ, Spyer M, Walker AS, Gibb DM; ARROW Trial Team..

AIDS. 2015 Aug 24;29(13):1623-32. doi: 10.1097/QAD.0000000000000749.


Opportunities for improving the efficiency of paediatric HIV treatment programmes.

Revill PA, Walker S, Mabugu T, Nathoo KJ, Mugyenyi P, Kekitinwa A, Munderi P, Bwakura-Dangarembizi M, Musiime V, Bakeera-Kitaka S, Nahirya-Ntege P, Walker AS, Sculpher MJ, Gibb DM.

AIDS. 2015 Jan 14;29(2):201-10. doi: 10.1097/QAD.0000000000000518.


Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review.

Ara R, Basarir H, Keetharuth AD, Barbieri M, Weatherly HL, Sculpher MJ, Ahmed H, Brown S.

Int J Technol Assess Health Care. 2014 Oct;30(4):381-93. doi: 10.1017/S0266462314000531. Review.


Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients.

Oddershede L, Walker S, Paton N, Stöhr W, Dunn D, Sculpher MJ.

Value Health. 2014 Nov;17(7):A683. doi: 10.1016/j.jval.2014.08.2550. No abstract available.


Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Prendergast AJ, Gomo ZA, Thomason MJ, Musarurwa C, Mugyenyi P, Nahirya P, Kekitiinwa A, Gibb DM, Walker AS, Nathoo K; ARROW Trial Team..

Pediatr Infect Dis J. 2015 Feb;34(2):e23-31. doi: 10.1097/INF.0000000000000491.


The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application.

Espinoza MA, Manca A, Claxton K, Sculpher MJ.

Med Decis Making. 2014 Nov;34(8):951-64. doi: 10.1177/0272989X14538705.


Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials.

Epstein D, Sculpher MJ, Powell JT, Thompson SG, Brown LC, Greenhalgh RM.

Br J Surg. 2014 May;101(6):623-31. doi: 10.1002/bjs.9464.


Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

ARROW Trial team., Kekitiinwa A, Cook A, Nathoo K, Mugyenyi P, Nahirya-Ntege P, Bakeera-Kitaka S, Thomason M, Bwakura-Dangarembizi M, Musiime V, Munderi P, Naidoo-James B, Vhembo T, Tumusiime C, Katuramu R, Crawley J, Prendergast AJ, Musoke P, Walker AS, Gibb DM.

Lancet. 2013 Apr 20;381(9875):1391-403. doi: 10.1016/S0140-6736(12)62198-9.


Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.

Pitman RJ, Nagy LD, Sculpher MJ.

Vaccine. 2013 Jan 30;31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010.


Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force..

Value Health. 2012 Sep-Oct;15(6):835-42. doi: 10.1016/j.jval.2012.04.014.


Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force..

Med Decis Making. 2012 Sep-Oct;32(5):722-32.


The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.

Brown LC, Powell JT, Thompson SG, Epstein DM, Sculpher MJ, Greenhalgh RM.

Health Technol Assess. 2012;16(9):1-218. doi: 10.3310/hta16090.


The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).

Manca A, Asseburg C, Bravo Vergel Y, Seymour MT, Meade A, Stephens R, Parmar M, Sculpher MJ.

Value Health. 2012 Jan;15(1):22-31. doi: 10.1016/j.jval.2011.07.008.

Items per page

Supplemental Content

Loading ...
Support Center